RE:RE:RE:RE:RE:Odds....it takes at least to things for a company to be successfull...
a good or visionary product and a good business/sales team.
I bought shares of PMED because I speculated (speculated - not invested!) that the result of their 3000 people impairment studies in India would proove their technology. I had doubts wrt the business part of the story. I have become rather critical when they started the cooperation with Juiceworks and nothing came out of it, although their Covid-19 scanners should have been in high demand if working properly. I also wondered by - if everything was really as rosy as promised - why no comapny with big pockets took them out (PEMEX could easily be swallowed by the big Indian compoanies who know all the results). Half a year later we have not heard anything from their 3000 people trials (results are actually long overdue) and except for promises (paid reports, interviews to internet outlets, distribution agreements) we didn't hear much about revenues, not to mention earnings. The result is a frustrated shareholder base (except for some promoters whose motives cannot be evaluated) and a seriously declining share price.
NEVERTHELSS, if the technology works and can be deployed at a resonable price, PMEX will be a winner and the share price will be several bucks. Hence I hold my position, but watch it closely.
L.